Trump administration appeals ruling that blocked Kennedy's vaccine policy overhaul

The Trump administration filed a formal appeal Wednesday challenging a federal judge's order that dismantled key parts of Health Secretary Robert F. Kennedy Jr.'s push to reshape the nation's childhood vaccine schedule, a ruling that halted a CDC advisory committee meeting and barred 13 of its newly appointed members from serving.

The Department of Justice filed its notice of appeal targeting the March 16 ruling by Boston-based U.S. District Judge Brian Murphy, who found that Kennedy's reconstituted Advisory Committee on Immunization Practices was unlawfully assembled. The case now heads to the 1st U.S. Circuit Court of Appeals, also based in Boston, with the possibility of eventually reaching the U.S. Supreme Court.

The fight is straightforward: Kennedy moved to slim down the childhood immunization schedule and stock the panel that advises the CDC with members who share his skepticism. Murphy said he broke the law doing it. The administration says Murphy is an activist judge who keeps overstepping, and keeps getting reversed.

What Murphy's ruling actually did

Murphy's March 16 order did more than pause a bureaucratic process. It struck at the core of Kennedy's health agenda. The judge concluded that 13 members of ACIP had been selected through what he called a "tainted" appointment process and barred every one of them from serving. Two days later, an ACIP meeting was scheduled to begin. It never happened. The committee postponed the session after the ruling landed.

The scope of the injunction went further than the panel itself. Fox News reported that Murphy's preliminary injunction stayed a January 2026 immunization schedule that had reduced the number of vaccine requirements for children, and also invalidated the newly appointed advisory committee's decisions while the case proceeds.

Breitbart reported that the blocked recommendations included flu, rotavirus, hepatitis A, hepatitis B, some meningitis vaccines, and RSV, a substantial portion of the routine childhood schedule. The judge said Kennedy likely violated federal law and procedures when he dismissed all 17 existing ACIP members and replaced them with new appointees.

Richard Hughes IV, an attorney representing the American Academy of Pediatrics, put it bluntly: "ACIP as currently constituted cannot meet."

Murphy's record and the administration's frustration

This is not the first time Murphy has blocked a Trump administration initiative. The president and his allies have repeatedly clashed with the judge, who has also intervened in parts of the administration's immigration agenda. That history is central to how the White House and DOJ are framing the appeal.

Acting U.S. Attorney General Todd Blanche took to social media to call Murphy's ruling "lawless" and an "activist decision." His full post, as reported by Just The News, went further:

"How many times can Judge Murphy get reversed in one year? The same day he is stayed for repeatedly refusing to follow the law, he issues another activist decision. We will keep appealing these lawless decisions, and we will keep winning. The question is, how much embarrassment can this Judge take?"

That timing matters. Blanche noted that the vaccine ruling dropped on the same day the 1st Circuit overturned Murphy in a separate deportation case. The pattern, Murphy blocks, the administration appeals, higher courts intervene, has become a recurring feature of the legal landscape around this judge's courtroom.

Fox News noted that conservatives and DOJ officials have criticized Murphy as an activist whose high-profile rulings on Trump administration policies have been reversed or stayed on appeal. Whether the vaccine case follows the same trajectory remains an open question, but the administration is clearly betting it will.

The substance behind the legal fight

Kennedy's vaccine agenda has been one of the most polarizing elements of the administration's health policy. He championed a reduced childhood vaccination schedule, fired the entire existing ACIP panel, and replaced its members with individuals more aligned with his views on vaccine safety. The administration's broader push for medical autonomy has extended across multiple agencies.

Murphy's ruling rested on procedural grounds. He found that Kennedy likely violated federal law by disregarding established procedures, including the legally codified process for constituting ACIP. In his written opinion, the judge was pointed:

"There is a method to how these decisions historically have been made, a method scientific in nature and codified into law through procedural requirements. Unfortunately, the Government has disregarded those methods and thereby undermined the integrity of its actions."

That language frames the dispute as one of process, not necessarily of policy substance. Murphy did not rule that Kennedy's preferred vaccine schedule was medically wrong. He ruled that Kennedy went about changing it the wrong way, by gutting the advisory body and installing hand-picked replacements without following the required appointment procedures.

Kennedy appointee Dr. Robert Malone offered a measured response: "A district court order is a delay, not a defeat." That framing tracks with the administration's broader confidence that appellate courts will side with the executive branch's authority to shape its own advisory panels.

The political stakes

AP News reported that the ruling may give the White House political cover to distance itself from Kennedy's most controversial vaccine positions ahead of the midterms. Kennedy's agenda has drawn fire not only from the medical establishment but from some within the Republican coalition who worry about the electoral cost of appearing hostile to childhood immunization.

The administration's health-policy portfolio extends well beyond vaccines. Recent moves on pharmaceutical pricing deals and personnel decisions around key health roles have shown a White House willing to make aggressive plays, and to course-correct when needed.

Whether Kennedy's vaccine overhaul survives in its current form depends on what the 1st Circuit does next. The administration has demonstrated a willingness to take these fights all the way to the Supreme Court, and Murphy's track record of getting reversed gives the DOJ reason for confidence.

But the procedural vulnerabilities Murphy identified are real. If Kennedy's team cut corners on how ACIP members were appointed, and the judge's finding that all 13 went through a "tainted" process suggests they did, the appellate court will have to decide whether the executive branch's broad authority over advisory panels extends to ignoring the statutory rules that govern them.

The broader question of who gets to shape federal vaccine policy, political appointees or entrenched advisory structures, isn't going away. The administration has signaled it intends to recalibrate health-related appointments when the politics demand it, and internal tensions over how far to push on vaccines have surfaced across multiple agencies.

Meanwhile, the ACIP meeting that was supposed to happen two days after the March 16 ruling remains in limbo. The committee that advises the CDC on which vaccines to recommend, a body whose guidance shapes what pediatricians across the country tell parents, cannot convene under its current membership. Thirteen members sit barred from the table by a single district judge.

The administration's appeal will test whether Murphy's procedural objections hold up, or whether they represent exactly the kind of judicial overreach that accountability-minded conservatives have been pushing back against for years.

What comes next

The 1st Circuit will now decide whether Murphy's injunction stands. Given that the same court recently overturned Murphy in an immigration case, the administration has reason to expect a favorable hearing. But vaccine policy carries different legal and political weight than deportation orders, and the appellate panel may approach the procedural questions with fresh eyes.

If the injunction holds, Kennedy's vaccine agenda stalls indefinitely, and the childhood immunization schedule reverts to its pre-January 2026 form while the case plays out. If the 1st Circuit reverses Murphy, the reconstituted ACIP could resume its work and the slimmed-down schedule could take effect.

Either way, the case will likely reach the Supreme Court eventually. The stakes, who controls federal vaccine recommendations, and how much deference courts owe the executive branch on advisory-panel appointments, guarantee it.

One district judge in Boston shouldn't get to decide the nation's vaccine policy. If the process was flawed, fix the process. But the answer to procedural shortcuts isn't a judicial veto over the elected executive branch's authority to govern.